Transforming Cancer Treatment

OncoNOx ApS

OncoNOx is pharmaceutical company focused on the devlopment of innovative treatments by transforming already marketed drugs into novel, proprietary molecules with anti-cancer and/or anti-inflammatory properties and improved therapeutic profile.

OncoNOx was founded in 2011 by a highly experienced group of scientists and biotech executives (see Founders) and has strong ties to research groups in Italy, the US, and Serbia.